Format

Send to

Choose Destination
Trends Immunol. 2003 May;24(5):249-53.

Altering T-cell activation by targeting the multidomain tyrosine kinase Itk.

Author information

1
Immunology and Oncology Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 4000, Princeton, NJ 08543, USA.
PMID:
12738418
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center